Back
ESC Premium Access

Potential eligibility for low dose rivaroxaban treatment in a "real world" population of Spanish patients with stable coronary artery disease: a subanalysis of the CICCOR registry

Session: Coronary Artery Disease (Chronic) ePosters
Topic: Pharmacotherapy
Speaker: Doctor M. Ruiz Ortiz (Cordoba, ES)
Event: ESC Congress 2020

Congress Presentation

Add to my library

Like

About the speaker

Doctor Martin Ruiz Ortiz

University Hospital Queen Sofia, Cordoba (Spain)
0 follower

233 more presentations in this session

Diabetes and pre-infarct angina. Time to rethink comorbidities in the reperfusion-injury phenomenon?

Speaker: Doctor M. Fontes Oliveira (Porto, PT)

Access
Abstract
Slides
Like
Thumbnail

Functional assessment of myocardial ischemia by intracoronary electrocardiogram

Speaker: Doctor M. Bigler (Bern, CH)

Access
Abstract
Slides
Like
Thumbnail

Plaque instability in acute coronary syndromes: a possible pathogenic role of gut microbial communities

Speaker: Doctor P. Eugenia (Rome, IT)

Access
Abstract
Slides
Like
Thumbnail

Insights from microRNAs into the pathophysiology of coronary and multiterritorial atherosclerosis

Speaker: Doctor T. Silva (Lisbon, PT)

Access
Abstract
Slides
Like
Thumbnail

Integrated analysis of DNA methylation profile in HLA-G gene and imaging in coronary heart disease

Speaker: Assistant Professor C. Schiano (Naples, IT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Coronary Artery Disease (Chronic) ePosters

Speakers: Doctor M. Ruiz Ortiz, Doctor M. Fontes Oliveira, Doctor M. Bigler, Doctor P. Eugenia, Doctor T. Silva...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources